For decades, health officials have set their sites on eradicating tuberculosis. Although the number of active TB cases has decreased in the United States and other developed countries, it remains widespread around the world. In fact, TB has regained the inglorious distinction of being the infectious disease that kills more people than any other, according to Kevin Fennelly, MD, MPH, chair of the ATS Assembly on Pulmonary Infections and TB.
2018 Conference Daily
From Spanish Flu to Ebola
Viruses evolve principally to survive and propagate. Killing the host is not part of that survival plan. When viruses go rogue, bad things happen. In talking about rogue viruses, Joshua Lederberg, the microbial geneticist and Nobel Laureate, said, “The single biggest threat to man’s continued dominance on the planet is the virus.”
New ATS Executive Director
ATS has a new executive director. Karen Collishaw, MPP, a highly experienced medical association leader, joined the ATS at the end of April after a national search. She succeeds Stephen C. Crane, PhD, MPH, who has served as ATS executive director since 2007 and is retiring.
Debunking Medical Myths
Exciting advances in iPS cell differentiation and ex vivo lung tissue bioengineering are gaining new attention as potential therapies for lung disease and transplantation.
Proteins Could be Key to Rare Lung Disorders
Pediatric rare lung diseases, including disorders such as childhood interstitial and diffuse lung diseases primary ciliary dyskinesia, and lung involvement in systemic juvenile inflammatory arthritis, are associated with high morbidity and are often life-threatening. These disorders are poorly understood, under-recognized, and have limited evidence-based therapeutic options.
Sunday Awards Session Honors Four Recipients
Four renowned physicians and researchers will be honored during Sunday’s Awards Session, featuring the Amberson Lecture and the presentation of the Trudeau Medal and two Distinguished Achievement Awards.
Should There Be a Global Approach to Sleep Medicine?
Although the global burden of sleep disorders remains unknown, it is estimated that obstructive sleep apnea affects nearly 1 billion people worldwide—and that’s a conservative number, according to Atul Malhotra, MD, of the University of California at San Diego.
Recognition Award Winners to Present Research
Four outstanding scientists have been selected to receive the Recognition Award for Scientific Accomplishments. The awards recognize scientific contributions in basic or clinical research that enhance the understanding, prevention, and treatment of respiratory disease or critical illness. Awardees will each make a 25-minute presentation on their research.
Fluid Administration in Sepsis
Administration of intravenous fluid is one of the key therapies in the ICU for treating one of our most common and lethal diseases—sepsis. There’s been a large reduction in sepsis mortality, which is partially attributable to early and aggressive fluid administration. However, several recent investigations have raised questions about the appropriateness of current fluid practice.
ATS Foundation Recognizes 2017 Donors
The ATS Foundation is pleased to recognize our generous donors who made gifts between
Jan. 1, 2017, and Dec. 31, 2017.